Nonviral delivery vehicles for use in short hairpin RNA-based cancer therapies

References

• Wolff JA, Malone RW, Williams P et al. Direct gene transfer into mouse muscle in vivo. Science247(4949 Pt 1), 1465–1468 (1990).
   PubMed Web of Science ®Google Scholar
• Nishkawa M, Huang L. Nonviral vectors in the new millennium: delivery barriers in gene transfer. Hum. Gene Ther.12(8), 861–870 (2001).
   PubMedGoogle Scholar
• Matzke MA, Birchler JA. RNAi-mediated pathways in the nucleus. Nat. Rev. Genet.6(1), 24–35 (2005).
   PubMed Web of Science ®Google Scholar
• Paddison PJ, Caudy AA, Bernstein E, Hannon GJ, Conklin DS. Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev.16(8), 948–958 (2002).
   PubMed Web of Science ®Google Scholar
• Stein U, Stege A, Walther W, Lage H. Complete in vivo reversal of the multidrug resistance (MDR) phenotype in a breast cancer model by jet-injection of anti-MDR1 short hairpin RNA-encoding plasmid DNA. Mol. Ther. (2006) (In Press).
   Google Scholar
• Lage H. Potential applications of RNA interference technology in the treatment of cancer. Future Oncol.1(1), 103–113 (2005).
   PubMedGoogle Scholar
• Bantounas I, Phylactoula LA, Uney JB. RNA interference and the use of small interfering RNA to study gene function in mammalian systems. J. Mol. Endocrinol.33(3), 545–557 (2004).
   PubMed Web of Science ®Google Scholar
• Wadhwa R, Kaul SC, Miyagishi M, Taira K. Vectors for RNA interference. Curr. Opin. Mol. Ther.6(4), 367–372 (2004).
   PubMed Web of Science ®Google Scholar
• Marsden PA. RNA interference as potential therapy – not so fast. N. Engl. J. Med.355(9), 953–954 (2006).
   PubMed Web of Science ®Google Scholar
• Grimm D, Streetz KL, Jopling CL et al. Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature441(7092), 537–541 (2006).
   PubMed Web of Science ®Google Scholar
• Balter M. Gene therapy on trial. Science288(5468), 951–957 (2000).
   PubMedGoogle Scholar
• Check E. A tragic setback. Nature420(6912), 116–118 (2002).
   PubMed Web of Science ®Google Scholar
• Nishikawa M, Hashida M. Nonviral approaches satisfying various requirements for effective in vivo gene therapy. Biol. Pharm. Bull.25(3), 275–283 (2002).
   PubMed Web of Science ®Google Scholar
• Walther W, Stein U, Fichtner I et al. Nonviral in vivo gene delivery into tumors using a novel low volume jet-injection technology. Gene Ther.8(3), 173–180 (2001).
   PubMed Web of Science ®Google Scholar
• Schatzlein AG, Zinselmeyer BH, Elouzi A et al. Preferential liver gene expression with polypropylenimine dendrimers. J. Control. Release101(1–3), 247–258 (2005).
   PubMed Web of Science ®Google Scholar
• Kircheis R, Blessing T, Brunner S, Wightman L, Wagner E. Tumor targeting with surface-shielded ligand–polycation DNA complexes. J. Control. Release72(1–3), 165–170 (2001).
   PubMed Web of Science ®Google Scholar
• Barron LG, Gagne L, Szoka FC Jr. Lipoplex-mediated gene delivery to the lung occurs within 60 minutes of intravenous administration. Hum. Gene Ther.10(10), 1683–1694 (1999).
   PubMed Web of Science ®Google Scholar
• Hughes JA, Rao GA. Targeted polymers for gene delivery. Expert Opin. Drug Deliv.2(1), 145–157 (2005).
   PubMed Web of Science ®Google Scholar
• Hilgenbrink AR, Low PS. Folate receptor-mediated drug targeting: from therapeutics to diagnostics. J. Pharm. Sci.94(10), 2135–2146 (2005).
   PubMed Web of Science ®Google Scholar
• Anwer K, Logan M, Tagliaferri F et al. Synthetic glycopeptide-based delivery systems for systemic gene targeting to hepatocytes. Pharm. Res.17(4), 451–459 (2000).
   PubMedGoogle Scholar
• Singh M. Transferrin as a targeting ligand for liposomes and anticancer drugs. Curr. Pharm. Des.5(6), 443–451 (1999).
   PubMed Web of Science ®Google Scholar
• Li D, Wang QQ, Tang GP et al. Receptor-mediated gene delivery using polyethylenimine (PEI) coupled with polypeptides targeting FGF receptors on cells surface. J. Zhejiang Univ. Sci. B7(11), 906–911 (2006).
   PubMedGoogle Scholar
• Liu X, Tian P, Yu Y et al. Enhanced antitumor effect of EGF R-targeted p21WAF-1 and GM-CSF gene transfer in the established murine hepatoma by peritumoral injection. Cancer Gene Ther.9(1), 100–108 (2002).
   PubMed Web of Science ®Google Scholar
• Backer MV, Gaynutdinov TI, Patel V et al. Vascular endothelial growth factor selectively targets boronated dendrimers to tumor vasculature. Mol. Cancer Ther.4(9), 1423–1429 (2005).
   PubMed Web of Science ®Google Scholar
• Mori T. Cancer-specific ligands identified from screening of peptide-display libraries. Curr. Pharm. Des.10(19), 2335–2343 (2004).
   PubMed Web of Science ®Google Scholar
• Lee JF, Stovall GM, Ellington AD. Aptamer therapeutics advance. Curr. Opin. Chem. Biol.10(3), 282–289 (2006).
   PubMed Web of Science ®Google Scholar
• Farokhzad OC, Cheng J, Teply BA et al. Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Proc. Natl Acad. Sci. USA103(16), 6315–6320 (2006).
   PubMed Web of Science ®Google Scholar
• Nimjee SM, Rusconi CP, Sullenger BA. Aptamers: an emerging class of therapeutics. Annu. Rev. Med.56, 555–583 (2005).
   PubMed Web of Science ®Google Scholar
• Park TG, Jeong JH, Kim SW. Current status of polymeric gene delivery systems. Adv. Drug Deliv. Rev.58(4), 467–486 (2006).
   PubMed Web of Science ®Google Scholar
• Gpdbey WT, Barry MA, Saggau P, Wu KK, Mikos AG. Poly(ethylenimine)-mediated transfection: a new paradigm for gene delivery. J. Biomed. Mater. Res.51(3), 321–328 (2000).
   PubMedGoogle Scholar
• Thomas M, Klibanov AM. Enhancing polyethylenimine’s delivery of plasmid DNA into mammalian cells. Proc. Natl Acad. Sci. USA99(23), 14640–14645 (2002).
   PubMed Web of Science ®Google Scholar
• Boussif O, Lezoualc’h F, Zanta MA et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc. Natl Acad. Sci. USA92(16), 7297–7301 (1995).
   PubMed Web of Science ®Google Scholar
• Garnett MC. Gene-delivery systems using cationic polymers. Crit. Rev. Ther. Drug Carrier Syst.16(2), 147–207 (1999).
   PubMed Web of Science ®Google Scholar
• Wightman L, Kircheis R, Rossler V et al. Different behavior of branched and linear polyethylenimine for gene delivery in vitro and in vivo. J. Gene Med.3(4), 362–372 (2001).
   PubMed Web of Science ®Google Scholar
• Jeong JH, Song SH, Lim DW, Lee H, Park TG. DNA transfection using linear poly(ethylenimine) prepared by controlled acid hydrolysis of poly(2-ethyl-2-oxazoline). J. Control. Release73(2–3), 391–399 (2001).
   PubMed Web of Science ®Google Scholar
• Petersen H, Fechner PM, Martin AL et al. Polyethylenimine-graft-poly(ethylene glycol) copolymers: influence of copolymer block structure on DNA complexation and biological activities as gene delivery system. Bioconjug. Chem.13(4), 845–854 (2002).
   PubMed Web of Science ®Google Scholar
• Chiu SJ, Ueno NT, Lee RJ. Tumor-targeted gene delivery via anti-HER2 antibody (trastuzumab, Herceptin) conjugated polyethylenimine. J. Control. Release97(2), 357–369 (2004).
   PubMed Web of Science ®Google Scholar
• Merdan T, Callahan J, Petersen H et al. Polyethylene glycol (PEG)ylated polyethylenimine-Fab´ antibody fragment conjugates for targeted gene delivery to human ovarian carcinoma cells. Bioconjug. Chem.14(5), 989–996 (2003).
   PubMed Web of Science ®Google Scholar
• Min SH, Lee DC, Lim MJ et al. A composite gene delivery system consisting of polyethylenimine and an amphipathic peptide KALA. J. Gene Med.8(12), 1425–1434 (2006).
   PubMed Web of Science ®Google Scholar
• Guan H, Zhou Z, Wang H et al. A small interfering RNA targeting vascular endothelial growth factor inhibits Ewing’s sarcoma growth in a xenograft mouse model. Clin. Cancer Res.11(7), 2662–2669 (2005).
   PubMed Web of Science ®Google Scholar
• Moriguchi R, Kogure K, Akita H et al. A multifunctional envelope-type nano device for novel gene delivery of siRNA plasmids. Int. J. Pharm.301(1–2), 277–285 (2005).
   PubMed Web of Science ®Google Scholar
• Dufes C, Uchegbu IF, Schatzlein AG. Dendrimers in gene delivery. Adv. Drug Deliv. Rev.57(15), 2177–2202 (2005).
   PubMed Web of Science ®Google Scholar
• Urdea MS, Horn T. Dendrimer development. Science261(5121), 534 (1993).
   PubMedGoogle Scholar
• Alper J. Rising chemical “stars” could play many roles. Science251(5001), 1562–1564 (1991).
   PubMed Web of Science ®Google Scholar
• Bielinska AU, Chen C, Johnson J, Baker JR Jr. DNA complexing with polyamidoamine dendrimers: implications for transfection. Bioconjug. Chem.10(5), 843–850 (1999).
   PubMed Web of Science ®Google Scholar
• Majoros IJ, Thomas TP, Mehta CB, Baker JR Jr. Poly(amidoamine) dendrimer-based multifunctional engineered nanodevice for cancer therapy. J. Med. Chem.48(19), 5892–5899 (2005).
   PubMed Web of Science ®Google Scholar
• Kim JB, Choi JS, Nam K et al. Enhanced transfection of primary cortical cultures using arginine-grafted PAMAM dendrimer, PAMAM–Arg. J. Control. Release114(1), 110–117 (2006).
   PubMed Web of Science ®Google Scholar
• Shukla R, Thomas TP, Peters JL et al. HER2 specific tumor targeting with dendrimer conjugated anti-HER2 mAb. Bioconjug. Chem.17(5), 1109–1115 (2006).
   PubMed Web of Science ®Google Scholar
• Tack F, Bakker A, Maes S et al. Modified poly(propylene imine) dendrimers as effective transfection agents for catalytic DNA enzymes (DNAzymes). J. Drug Target.14(2), 69–86 (2006).
   PubMed Web of Science ®Google Scholar
• Read ML, Singh S, Ahmed Z et al. A versatile reducible polycation-based system for efficient delivery of a broad range of nucleic acids. Nucleic Acids Res.33(9), E86 (2005).
   PubMed Web of Science ®Google Scholar
• Mamede M, Saga T, Ishimori T et al. Hepatocyte targeting of 111In-labeled oligo-DNA with avidin or avidin-dendrimer complex. J. Control. Release95(1), 133–141 (2004).
   PubMedGoogle Scholar
• Xiong XY, Tam KC, Gan LH. Polymeric nanostructures for drug delivery applications based on pluronic copolymer systems. J. Nanosci. Nanotechnol.6(9–10), 2638–2650 (2006).
   PubMed Web of Science ®Google Scholar
• Jang JS, Kim SY, Lee SB et al. Poly(ethylene glycol)/poly(ε-caprolactone) diblock copolymeric nanoparticles for non-viral gene delivery: the role of charge group and molecular weight in particle formation, cytotoxicity and transfection. J. Control. Release113(2), 173–182 (2006).
   PubMed Web of Science ®Google Scholar
• Conwell CC, Huang L. Recent advances in non-viral gene delivery. Adv. Genet.53, 3–18 (2005).
   PubMedGoogle Scholar
• Seth P. Vector-mediated cancer gene therapy: an overview. Cancer Biol. Ther.4(5), 512–517 (2005).
   PubMed Web of Science ®Google Scholar
• Gardlik R, Palffy R, Hodosy J et al. Vectors and delivery systems in gene therapy. Med. Sci. Monit.11(4), RA110–RA121 (2005).
   PubMed Web of Science ®Google Scholar
• Dang JM, Leong KW. Natural polymers for gene delivery and tissue engineering. Adv. Drug Deliv. Rev.58(4), 487–499 (2006).
   PubMed Web of Science ®Google Scholar
• Storrie H, Mooney DJ. Sustained delivery of plasmid DNA from polymeric scaffolds for tissue engineering. Adv. Drug Deliv. Rev.58(4), 500–514 (2006).
   PubMed Web of Science ®Google Scholar
• Tiera MJ, Winnik FO, Fernandes JC. Synthetic and natural polycations for gene therapy: state of the art and new perspectives. Curr. Gene Ther.6(1), 59–71 (2006).
   PubMed Web of Science ®Google Scholar
• Sano A, Maeda M, Nagahara S et al. Atelocollagen for protein and gene delivery. Adv. Drug Deliv. Rev.55(12), 1651–1677 (2003).
   PubMed Web of Science ®Google Scholar
• Wang J, Lee IL, Lim WS et al. Evaluation of collagen and methylated collagen as gene carriers. Int. J. Pharm.279(1–2), 115–126 (2004).
   PubMed Web of Science ®Google Scholar
• Cohen-Sacks H, Elazar V, Gao J et al. Delivery and expression of pDNA embedded in collagen matrices. J. Control. Release95(2), 309–320 (2004).
   PubMed Web of Science ®Google Scholar
• Kushibiki T, Nagata-Nakajima N, Sugai M, Shimizu A, Tabata Y. Enhanced anti-fibrotic activity of plasmid DNA expressing small interference RNA for TGF-β type II receptor for a mouse model of obstructive nephropathy by cationized gelatin prepared from different amine compounds. J. Control. Release110(3), 610–617 (2006).
   PubMed Web of Science ®Google Scholar
• Matsumoto G, Kushibiki T, Kinoshita Y et al. Cationized gelatin delivery of a plasmid DNA expressing small interference RNA for VEGF inhibits murine squamous cell carcinoma. Cancer Sci.97(4), 313–321 (2006).
   PubMed Web of Science ®Google Scholar
• Chandy T, Sharma CP. Chitosan – as a biomaterial. Biomater. Artif. Cells Artif. Organs18(1), 1–24 (1990).
   PubMed Web of Science ®Google Scholar
• Leong KW, Mao HQ, Truong-Le VL et al. DNA-polycation nanospheres as non-viral gene delivery vehicles. J. Control. Release53(1–3), 183–193 (1998).
   PubMed Web of Science ®Google Scholar
• Borchard G. Chitosans for gene delivery. Adv. Drug Deliv. Rev.52(2), 145–150 (2001).
   PubMed Web of Science ®Google Scholar
• Koping-Hoggard M, Tubulekas I, Guan H et al. Chitosan as a nonviral gene delivery system. Structure-property relationships and characteristics compared with polyethylenimine in vitro and after lung administration in vivo. Gene Ther.8(14), 1108–1121 (2001).
   PubMed Web of Science ®Google Scholar
• Hwang SJ, Bellocq NC, Davis ME. Effects of structure of β-cyclodextrin-containing polymers on gene delivery. Bioconjug. Chem.12(2), 280–290 (2001).
   PubMed Web of Science ®Google Scholar
• Pun SH, Bellocq NC, Liu A et al. Cyclodextrin-modified polyethylenimine polymers for gene delivery. Bioconjug. Chem.15(4), 831–840 (2004).
   PubMed Web of Science ®Google Scholar
• Li S. Hydrolytic degradation characteristics of aliphatic polyesters derived from lactic and glycolic acids. J. Biomed. Mater. Res.48(3), 342–353 (1999).
   PubMed Web of Science ®Google Scholar
• Hedley ML. Formulations containing poly(lactide-co-glycolide) and plasmid DNA expression vectors. Expert Opin. Biol. Ther.3(6), 903–910 (2003).
   PubMed Web of Science ®Google Scholar
• Dhiman N, Dutta M, Khuller GK. Poly (dl-lactide-co-glycolide) based delivery systems for vaccines and drugs. Indian J. Exp. Biol.38(8), 746–752 (2000).
   PubMedGoogle Scholar
• Singh M, Fang JH, Kazzaz J et al. A modified process for preparing cationic polylactide-co-glycolide microparticles with adsorbed DNA. Int. J. Pharm.327(1–2), 1–5 (2006).
   PubMed Web of Science ®Google Scholar
• Cheng J, Teply BA, Sherifi I et al. Formulation of functionalized PLGA–PEG nanoparticles for in vivo targeted drug delivery. Biomaterials28(5), 869–876 (2007).
   PubMed Web of Science ®Google Scholar
• Wasungul L, Hoekstra D. Cationic lipids, lipoplexes and intracellular delivery of genes. J. Control. Release116(2), 255–264 (2006).
   PubMedGoogle Scholar
• Dass CR, Choong PF. Selective gene delivery for cancer therapy using cationic liposomes: in vivo proof of applicability. J. Control. Release113(2), 155–163 (2006).
   PubMed Web of Science ®Google Scholar
• Oberle V, Bakowsky U, Zuhorn IS, Hoekstra D. Lipoplex formation under equilibrium conditions reveals a three-step mechanism. Biophys. J.79(3), 1447–1454 (2000).
   PubMed Web of Science ®Google Scholar
• Hashida M, Kawakami S, Yamashita F. Lipid carrier systems for targeted drug and gene delivery. Chem. Pharm. Bull.53(8), 871–880 (2005).
   PubMed Web of Science ®Google Scholar
• Fumoto S, Kawakami S, Ito Y et al. Enhanced hepatocyte-selective in vivo gene expression by stabilized galactosylated liposome/plasmid DNA complex using sodium chloride for complex formation. Mol. Ther.10(4), 719–729 (2004).
   PubMed Web of Science ®Google Scholar
• Kawakami S, Hattori Y, Lu Y et al. Effect of cationic charge on receptor-mediated transfection using mannosylated cationic liposome/plasmid DNA complexes following the intravenous administration in mice. Pharmazie59(5), 405–408 (2004).
   PubMed Web of Science ®Google Scholar
• Shi N, Zhang Y, Zhu C, Borador J, Pardridge WM. Brain-specific expression of an exogenous gene after i.v. administration. Proc. Natl Acad. Sci. USA98(22), 12754–12759 (2001).
   PubMed Web of Science ®Google Scholar
• Hofland HE, Masson C, Iginla S et al. Folate-targeted gene transfer in vivo. Mol. Ther.5(6), 739–744 (2002).
   PubMed Web of Science ®Google Scholar
• Zhang Y, Boado RJ, Pardridge WM. In vivo knockdown of gene expression in brain cancer with intravenous RNAi in adult rats. J. Gene Med.5(12), 1039–1045 (2003).
   PubMed Web of Science ®Google Scholar
• Pardridge WM. Intravenous, non-viral RNAi gene therapy of brain cancer. Expert Opin. Biol. Ther.4(7), 1103–1113 (2004).
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang YF, Bryant J et al. Intravenous RNA interference gene therapy targeting the human epidermal growth factor receptor prolongs survival in intracranial brain cancer. Clin. Cancer Res.10(11), 3667–3677 (2004).
   PubMed Web of Science ®Google Scholar
• Mellor HR, Davies LA, Caspar H et al. Optimising non-viral gene delivery in a tumour spheroid model. J. Gene Med.8(9), 1160–1170 (2006).
   PubMedGoogle Scholar
• Hashimoto M, Morimoto M, Saimoto H et al. Gene transfer by DNA/mannosylated chitosan complexes into mouse peritoneal macrophages. Biotechnol. Lett.28(11), 815–821 (2006).
   PubMed Web of Science ®Google Scholar
• Moffatt S, Wiehle S, Cristiano RJ. A multifunctional PEI-based cationic polyplex for enhanced systemic p53-mediated gene therapy. Gene Ther.13(21), 1512–1523 (2006).
   PubMed Web of Science ®Google Scholar
• Kang HC, Kim S, Lee M, Bae YH. Polymeric gene carrier for insulin secreting cells: poly(l-lysine)-γ-sulfonylurea for receptor mediated transfection. J. Control. Release105(1–2), 164–176 (2005).
   PubMed Web of Science ®Google Scholar
• Zhu SG, Xiang JJ, Li XL et al. Poly(l-lysine)-modified silica nanoparticles for the delivery of antisense oligonucleotides. Biotechnol. Appl. Biochem.39(Pt 2), 179–187 (2004).
   PubMed Web of Science ®Google Scholar
• Vincent L, Varet J, Pille JY et al. Efficacy of dendrimer-mediated angiostatin and TIMP-2 gene delivery on inhibition of tumor growth and angiogenesis: in vitro and in vivo studies. Int. J. Cancer105(3), 419–429 (2003).
   PubMed Web of Science ®Google Scholar
• Koping-Hoggard M, Mel’Nikova YS, Varum KM, Lindman B, Artursson P. Relationship between the physical shape and the efficiency of oligomeric chitosan as a gene delivery system in vitro and in vivo. J. Gene Med.5(2), 130–141 (2003).
   PubMed Web of Science ®Google Scholar
• Hu-Lieskivan S, Heidel JD, Bartlett DW, Davis ME, Triche TJ. Sequence-specific knockdown of EWS-FLI1 by targeted, nonviral delivery of small interfering RNA inhibits tumor growth in a murine model of metastatic Ewing’s sarcoma. Cancer Res.65(19), 8984–8992 (2005).
   PubMedGoogle Scholar
• Wallace DG, Rosenblatt J. Collagen gel systems for sustained delivery and tissue engineering. Adv. Drug Deliv. Rev.55(12), 1631–1649 (2003).
   PubMed Web of Science ®Google Scholar
• Ochiya T, Nagahara S, Sano A, Itoh H, Terada M. Biomaterials for gene delivery: atelocollagen-mediated controlled release of molecular medicines. Curr. Gene Ther.1(1), 31–52 (2001).
   PubMedGoogle Scholar
• Young S, Wong M, Tabata Y, Mikos AG. Gelatin as a delivery vehicle for the controlled release of bioactive molecules. J. Control. Release109(1–3), 256–274 (2005).
   PubMed Web of Science ®Google Scholar
• Denis-Mize KS, Dupuis M, Singh M et al. Mechanisms of increased immunogenicity for DNA-based vaccines adsorbed onto cationic microparticles. Cell. Immunol.225(1), 12–20 (2003).
   PubMed Web of Science ®Google Scholar
• Saora P, Tyagi P, Allen TM. Ligand-targeted liposomes for cancer treatment. Curr. Drug Deliv.2(4), 369–381 (2005).
   PubMedGoogle Scholar
• Carpenter M, Epperly MW, Agarwal A et al. Inhalation delivery of manganese superoxide dismutase–plasmid/liposomes protects the murine lung from irradiation damage. Gene Ther.12(8), 685–693 (2005).
   PubMed Web of Science ®Google Scholar
• Goyal P, Goyal K, Vijala Kumar SG et al. Liposomal drug delivery systems – clinical applications. Acta Pharm.55(1), 1–25 (2005).
   PubMedGoogle Scholar
• Kushibiki T, Nagata-Nakajima N, Sugai M, Shimizu A, Tabata Y. Delivery of plasmid DNA expressing small interference RNA for TGF-β type II receptor by cationized gelatin to prevent interstitial renal fibrosis. J. Control. Release105(3), 318–331 (2005).
   PubMed Web of Science ®Google Scholar
• Niola F, Evangelisti C, Campagnolo L et al. A plasmid-encoded VEGF siRNA reduces glioblastoma angiogenesis and its combination with interleukin-4 blocks tumor growth in a xenograft mouse model. Cancer Biol. Ther.5(2), 174–179 (2006).
   PubMed Web of Science ®Google Scholar